Conversations in CV Risk Assessment

Our approach to cardiovascular risk assessment is evolving, and it’s time to look beyond traditional markers like LDL and blood pressure. That’s why our Conversations in CV Risk Assessment collection brings together leading experts in cardiology, nephrology, endocrinology, and primary care to explore albuminuria and eGFR. These often-overlooked tools can not only uncover hidden cardiovascular risk long before symptoms appear, but they can also guide proactive, evidence-based interventions to prevent heart failure, stroke, and other serious outcomes.